Better Dividend: Abbott Laboratories (ABT) vs. AbbVie Inc (ABBV)
High yields aren't everything when you're searching for the perfect dividend stock.
Posts Tagged ‘Abbott Laboratories (ABT)’
This Acquisition Will Improve Abbott Laboratories (ABT)’s Business
Abbott Laboratories (NYSE:ABT)' bid to acquire IDEV Technologies by end-2013 will strengthen the former’s medical devices (Abbott Vascular) business especially in stent offerings...
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY): Healthcare Stocks to Consider Buying
Note: This article has been amended to remove TRADJENTA as Eli Lilly & Co.
Sinopec Shanghai Petrochemical Co. (ADR) (SHI), Abbott Laboratories (ABT): The Trends Investors Need to Watch in China’s Slowdown
A downbeat outlook from China's manufacturing sector couldn't hold back Hong Kong's HANG SENG INDEX (INDEXHANGSENG:HSI) from big gains this week, as the index pulled in gains...
Will AbbVie Inc (ABBV) Earnings Stay Healthy?
AbbVie Inc (NYSE:ABBV) will release its quarterly report on Friday, and with its stock having jumped considerably since it started trading as a separate entity, investors are ...
Abbott Laboratories (ABT) & ThermoGenesis Corp (KOOL): Two Medical Device Companies Making Smart Acquisitions
Due to the aging population in developed nations, rising incomes levels in emerging nations, and overall higher government spending in the healthcare sector, the medical industry...
Better Dividend: Johnson & Johnson (JNJ) vs. Abbott Laboratories (ABT)
Picking the best dividend stocks isn't just a matter of finding the highest-yielding picks.
The Procter & Gamble Company (PG), The Walt Disney Company (DIS): Five Stocks Every Parent Should Own
It's not just Kate Middleton and Prince William having a baby these days. There are a lot of new parents and parents-to-be out there.
Gilead Sciences, Inc. (GILD), AbbVie Inc (ABBV), Bristol Myers Squibb Co. (BMY): Three Future Winners and One Major Loser in the HCV Wars
The biotech industry is a cutthroat one, with companies constantly racing to get new treatments approved by the FDA ahead of their rivals.
Abbott Laboratories (ABT), Pfizer Inc. (PFE): How Will the Patent Cliff Affect These Pharmaceuticals?
The pharmaceutical sector is mainly about the pipeline of new products and patents.
Good Nutrition Helps Abbott Laboratories (ABT)’s Q2 Earnings Grow
Investors looking to find out how well Abbott Laboratories (NYSE:ABT) performed in the second quarter had reason to be confused this morning.
Abbott Laboratories (ABT), AbbVie Inc (ABBV): Why Investors Should Care About Hepatitis C
Hepatitis C, caused by the hepatitis C virus (HCV), is an infectious disease affecting the liver.
Mead Johnson Nutrition CO (MJN), Abbott Laboratories (ABT): Which Infant Formula Stock is a Best Buy Now?
I always consider a short-term stock price decline to be an opportunity for investors to accumulate a company’s shares at a low price.
Mead Johnson Nutrition CO (MJN): Is This Company’s Cash Cow Drying Up?
Shares of Mead Johnson Nutrition CO (NYSE:MJN) plunged recently, after Chinese regulators stated that they were investigating claims that foreign companies were intentionally...
Altria Group Inc (MO), Philip Morris International Inc. (PM): How to Play a Stronger Dollar, or Hedge Against a Falling One
Back in late March the head of US equity strategy for Deutsche Bank, David Bianco, stated that, "I’d welcome a stronger dollar...
Abbott Laboratories (ABT), AbbVie Inc (ABBV): 6-Month Checkup
Technically, Abbott Laboratories (NYSE:ABT) has been around for decades.
VIVUS, Inc. (VVUS): Obesity Drug Finally Hits Pharmacies
After gaining Food and Drug Administration approval nearly a year ago, patients can finally walk into a pharmacy and get their prescription for VIVUS, Inc.
Johnson & Johnson (JNJ), Bristol Myers Squibb Co. (BMY): Top Dividend Stocks in Big Pharma
When looking for the best dividend stocks, it's usually best to not chase the highest dividend.
Is the Time Ripe to Buy Johnson & Johnson (JNJ) Stock?
If you owned Johnson & Johnson (NYSE:JNJ) stock at the beginning of 2013, you're sitting atop gains of more than 20% right now.
Aegerion Pharmaceuticals, Inc. (AEGR), Arena Pharmaceuticals, Inc. (ARNA): Investment Opportunities in Drug Launches
There are investment opportunities in every sector, but biotechs launching new drugs offer a unique investment opportunity to take advantage of hyper-growth as sales increase ...
Abbott Laboratories (ABT), AbbVie Inc (ABBV): This Healthcare Giant is Definitely a Great Buy Now
I am always excited when a company plans to return more cash to its shareholders in both dividends and share buybacks.
Is Now a Great Time to Buy Abbott Laboratories (ABT)?
There's no question that Abbott Laboratories (NYSE:ABT) started 2013 with a bang. The year began with the spinoff of AbbVie Inc (NYSE:ABBV).
Abbott Laboratories (ABT), AbbVie Inc (ABBV): This FDA Approval Is Exciting News for Hepatitis-C Patients
Hepatitis-C is a contagious virus that attacks the liver and can be found in acute or chronic forms.
Valeant Pharmaceuticals Intl Inc (VRX), Abbott Laboratories (ABT): This Pharmaceutical Stock Promises Robust Returns
The healthcare sector has always been a subject of great interest to investors and analysts alike.
Abbott Laboratories (ABT), Merck & Co., Inc. (MRK): The Proprietary Drug Business Just Got Riskier
A new Supreme Court ruling presents pharmaceutical companies with a tough choice -- stop paying generic-drug producers to withhold generic options from the market, or risk getting...
Abbott Laboratories (ABT), VIVUS, Inc. (VVUS) – It’s Official: Obesity Is a Disease
The decision wasn't without debate, though. In fact, the AMA's Council on Science and Public Health actually recommended against calling obesity a disease.
Gilead Sciences, Inc. (GILD), Bristol Myers Squibb Co. (BMY): The Best Healthcare Bet
Gilead Sciences, Inc. (NASDAQ:GILD) has been one of the most prolific investments in the healthcare sector.
Abbott Loves Abbott Laboratories (ABT) Stock
Abbott Laboratories (NYSE:ABT) seems to think its stock is cheap enough to justify sinking a substantial amount of its nest egg into the company's stock.
Medtronic, Inc. (MDT): Should You Buy This Dividend Aristocrat?
As the market becomes more volatile and high-grade dividend stocks begin to fall in price an opportunity opens up to buy those stocks at a more reasonable price than the last ...
Identifying the Biggest Gem in Antares Pharma Inc (ATRS)’s Pipeline
Following the publication of my article on the blockbuster potential of Antares Pharma Inc (NASDAQ:ATRS)'s transformational product (Otrexup), I have been inundated with reader...
Mead Johnson Nutrition CO (MJN), Abbott Laboratories (ABT): These Companies Have a Formula for Success
As populations grow and as food safety concerns increase, parents are being very selective about the infant baby formulas they buy.
Yahoo! Inc. (YHOO), Virgin Media Inc. (VMED): Here’s What This 758% Gainer Has Been Buying
Today, let's look at investing giant Daniel Loeb, founder of the Third Point LLC hedge fund.
Mead Johnson Nutrition CO (MJN), Abbott Laboratories (ABT): Bet Big on Boomers and Babies
With more baby boomers hitting retirement age and their babies starting families (the so-called Echo Boom) several stocks are bound to benefit.
GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT): Tuesday’s Top Upgrades & Downgrades
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.
Abbott Laboratories (ABT), Celgene Corporation (CELG) & Three Pharma Companies to Buy in 2013
Currently, a majority of pharma companies are facing the issue of generic competition.
Do Hedge Funds and Insiders Love Abbott Laboratories (ABT)?
In the 21st century investor’s toolkit, there are tons of metrics investors can use to monitor Mr. Market. A pair of the best are hedge fund and insider trading movement.
General Electric Company (GE): Why This Stock Could Be a Smart Investment
Over the past few years, General Electric Company (NYSE:GE) has posted robust growth in several business divisions.
Will This Crush Medtronic, Inc. (MDT)’s Earnings?
On Tuesday, Medtronic, Inc. (NYSE:MDT) will release its latest quarterly results.
Merck & Co., Inc. (MRK), Seadrill Ltd (SDRL), Banco Santander, S.A. (ADR) (SAN): Here’s What This Big Market-Beater Has Been Buying and Selling
Today let's look at investment advisory firm Douglass Winthrop Advisors.
Abbott Laboratories (ABT), The Chubb Corporation (CB), And Three Stocks That Offer Protection From Market Tantrums
The economy is only just starting to chug along again. The situation in Europe is relatively unchanged, China is slowing down and banks are still de-leveraging.
BEAM Inc (BEAM), Abbott Laboratories (ABT): Some Investing Lessons To Pay Attention To
If I could send a message back in time to my younger self, I would only need to use four words, “Keep it simple, Stupid!” This is great advice for life in general, but especially...
VIVUS, Inc. (VVUS): You’ve Got To Spend Money To Make Money
VIVUS, Inc. (NASDAQ:VVUS) has the first part down.
Merck & Co., Inc. (MRK), Novo Nordisk A/S (ADR) (NVO): Who Should You Buy?
Recently, I have focused in on some companies that play a major role in diabetic's lives like mine.
Coinstar, Inc. (CSTR), AbbVie Inc (ABBV) & More Stocks Billionaire Ken Fisher Loves
For the past 15 years, investment guru Ken Fisher's stock picks have outperformed the overall market by more than 5% on average each year.
J.C. Penney Company, Inc. (JCP), Abbott Laboratories (ABT) & Today’s Three Worst Stocks
No matter the market, there will always be losers-a few lagging disappointments holding back a Wall Street rally or several big losers leading a bearish day.
ConocoPhillips (COP), Phillips 66 (PSX): Are These Spinoffs Investment Worthy?
There have been a number of high-profile spin-offs over the past few years.
Abbott Laboratories (ABT) Changes Its Focus
Abbott Laboratories (NYSE:ABT)' first-quarter earnings were boosted by its nutritional product lines, which include baby formula Similac, adult drink Ensure, and Glucerna bars...
Eli Lilly & Co. (LLY), GlaxoSmithKline plc (ADR) (GSK), And Why You Don’t Have to Run a Cartel to Make Big Profits in Drugs
The market for prescription and over-the-counter drugs is huge and hugely profitable.
Merck & Co., Inc. (MRK): The Foundations of the Pharmaceutical Industry
Merck & Co., Inc. (NYSE:MRK) took its first steps toward pharmaceutical dominance on April 30, 1953, when it merged with Sharp & Dohme, a pharmaceutical manufacturer.
Biopharma News: Arena Pharmaceuticals, Inc. (ARNA)’s Update, New VIVUS, Inc. (VVUS) Deal & More
Editor's Note: Related tickers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS, Inc. (NASDAQ:VVUS), Johnson & Johnson (NYSE:JNJ), Orexigen Therapeutics, Inc.
